Enhancing siRNA delivery by employing lipid nanoparticles

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954 · see citing works

Liposomal drug delivery systems: From concept to clinical applications

Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · see citing works

CpG Motifs in Bacterial DNA and Their Immune Effects

Krieg, A. Μ. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,570 · see citing works

Rational design of cationic lipids for siRNA delivery

Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · see citing works

Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape

Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681 · see citing works

RNAi-mediated gene silencing in non-human primates

Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · see citing works

Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations.

Felgner, J. H., Kumar, R., Sridhar, C. N., Wheeler, C. J., Tsai, Y.-L., Border, R., Ramsey, P., Martin, M. U., & Felgner, P. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41980-6 · Cited by 1,313 · see citing works

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267 · see citing works

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261 · see citing works

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

Akinc, A., Zumbuehl, A., Goldberg, M. S., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S., Nguyen, D. N., Fuller, J. E., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,228 · see citing works

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K. S., Jensen, K., Breen, W., Hartsough, K. C., Machemer, L., Radka, S. F., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168 · see citing works

Cationic liposome-mediated transfection

Felgner, P. L., & RINGOLD, G. M. (1989) · Nature · doi:10.1038/337387a0 · Cited by 989 · see citing works

Safety and efficacy of RNAi therapy for transthyretin amyloidosis

Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208760 · Cited by 971 · see citing works

Lipid-like materials for low-dose, in vivo gene silencing

Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969 · see citing works

Improved DNA: liposome complexes for increased systemic delivery and gene expression

Templeton, N. S., Lasiç, D. D., Frederik, P. M., Strey, H. H., Roberts, D. D., & Pavlakis, G. N. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-647 · Cited by 740 · see citing works

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

Frank-Kamenetsky, M. D., Grefhorst, A., Anderson, N. N., Racie, T., Bramlage, B., Akinc, A., Butler, D., Charissé, K., Dorkin, J. R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 635 · see citing works

On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids

Hafez, I., Maurer, N., & Cullis, P. R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601 · see citing works

Pharmacokinetics of stealth versus conventional liposomes: effect of dose

Allen, T. M., & Hansen, C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90201-i · Cited by 579 · see citing works

Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

Fitzgerald, K. J., Frank-Kamenetsky, M. D., Shulga‐Morskaya, S., Liebow, A., Bettencourt, B. R., Sutherland, J. E., Hutabarat, R. M., Clausen, V. A., Karsten, V., Cehelsky, J. E., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61914-5 · Cited by 574 · see citing works

Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids

Heyes, J., Palmer, L., Bremner, K., & MacLachlan, I. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.014 · Cited by 572 · see citing works

Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles

Mui, B. L., Tam, Y. K., Jayaraman, M., Ansell, S. M., Du, X., Tam, Y. Y. C., Lin, P. J. C., Chen, S., Narayanannair, J. K., Rajeev, K. G., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.66 · Cited by 509 · see citing works

Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine

Silverman, J. A., & Deitcher, S. R. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2042-4 · Cited by 474 · see citing works

Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes.

Chonn, A., Semple, S. C., & Cullis, P. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37026-7 · Cited by 461 · see citing works

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

Geisbert, T. W., Lee, A. C., Robbins, M., Geisbert, J. B., Honko, A. N., Sood, V., Johnson, J. C., de Jong, S. D., Tavakoli, I., Judge, A. D., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60357-1 · Cited by 457 · see citing works

Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures

Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454 · see citing works

Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo

Semple, S. C., Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00128-2 · Cited by 403 · see citing works

Gene Transfer with Synthetic Cationic Amphiphiles: Prospects for Gene Therapy

Behr, J. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00029a002 · Cited by 368 · see citing works

Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core

Leung, A. K. K., Hafez, I. M., Baoukina, S., Belliveau, N. M., Zhigaltsev, I. V., Afshinmanesh, E., Tieleman, D. P., Hansen, C. L., Hope, M. J., & Cullis, P. R. (2012) · The Journal of Physical Chemistry C · doi:10.1021/jp303267y · Cited by 364 · see citing works

Biochemistry of Lipids, Lipoproteins and Membranes

(1996) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)x6026-0 · Cited by 343 · see citing works

Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection

Wooddell, C. I., Rozema, D. B., Hoßbach, M., John, M., Hamilton, H., Chu, Q., Hegge, J., Klein, J. J., Wakefield, D. H., Oropeza, C. E., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.31 · Cited by 291 · see citing works

Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes

Koller, E., Vincent, T. M., Chappell, A. E., De, S., Manoharan, M., & Bennett, C. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr089 · Cited by 284 · see citing works

Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions

Chen, J., Li, Q., & Wang, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106420108 · Cited by 283 · see citing works

Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin

Karikó, K., Muramatsu, H., Keller, J. M., & Weissman, D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.7 · Cited by 282 · see citing works

Overcoming the Innate Immune Response to Small Interfering RNA

Judge, A. D., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.179 · Cited by 279 · see citing works

Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models

Webb, M., Harasym, T. O., Masin, D., Bally, M. B., & Mayer, L. D. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.430 · Cited by 243 · see citing works

Lipid-DNA Complexes Induce Potent Activation of Innate Immune Responses and Antitumor Activity When Administered Intravenously

DOW, S. W., Fradkin, L. G., Liggitt, D. H., Willson, A. P., Heath, T. D., & Potter, T. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1552 · Cited by 237 · see citing works

Spontaneous Entrapment of Polynucleotides upon Electrostatic Interaction with Ethanol-Destabilized Cationic Liposomes

Maurer, N., Wong, K. F., Stark, H., Louie, L. J., McIntosh, D. P., Wong, T., Scherrer, P., Semple, S. C., & Cullis, P. R. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)76202-9 · Cited by 232 · see citing works

Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes

Song, L. Y., AHKONG, Q. F., Rong, Q., Wang, Z., Ansell, S. M., Hope, M. J., & Mui, B. L. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00399-6 · Cited by 229 · see citing works

Immunogenicity and Rapid Blood Clearance of Liposomes Containing Polyethylene Glycol-Lipid Conjugates and Nucleic Acid

Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211 · see citing works

Why do Polyethylene Glycol-Coated Liposomes Circulate So Long?: Molecular Mechanism of Liposome Steric Protection with Polyethylene Glycol: Role of Polymer Chain Flexibility

Torchilinl, V. P., & Papisov, M. I. (1994) · Journal of Liposome Research · doi:10.3109/08982109409037068 · Cited by 173 · see citing works

Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format

Phua, K. K. L., Leong, K. W., & Nair, S. K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.029 · Cited by 159 · see citing works

Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing

Mahley, R. W., & Huang, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30889 · Cited by 159 · see citing works

Modulation of Membrane Fusion by Asymmetric Transbilayer Distributions of Amino Lipids

Bailey, A. L., & Cullis, P. R. (1994) · Biochemistry · doi:10.1021/bi00208a007 · Cited by 143 · see citing works

Membrane Fusion with Cationic Liposomes: Effects of Target Membrane Lipid Composition

Bailey, A. L., & Cullis, P. R. (1997) · Biochemistry · doi:10.1021/bi961173x · Cited by 142 · see citing works

The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse

Yan, X., Kuipers, F., Havekes, L. M., Havinga, R., Dontje, B., Poelstra, K., Scherphof, G. L., & Kamps, J. A. A. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.137 · Cited by 133 · see citing works

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN

de Jong, S. D., Chikh, G., Sekirov, L., Raney, S. G., Semple, S. C., Klimuk, S. K., Yuan, N., Hope, M., Cullis, P. R., & Tam, Y. K. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0276-x · Cited by 127 · see citing works

Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy

Zhang, L., Song, J., Cavigiolio, G., Ishida, B. Y., Zhang, S., Kane, J. P., Weisgraber, K. H., Oda, M. N., Rye, K.-A., Pownall, H. J., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.d010959 · Cited by 123 · see citing works

Liver as a target for oligonucleotide therapeutics

Sehgal, A., Vaishnaw, A. K., & Fitzgerald, K. J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.045 · Cited by 115 · see citing works

Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (Review)

Hope, M. J., Mui, B. L., Ansell, S. M., & AHKONG, Q. F. (1998) · Molecular Membrane Biology · doi:10.3109/09687689809027512 · Cited by 112 · see citing works

Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.

Mayer, L. D., Bally, M. B., Loughrey, H. C., Masin, D., & Cullis, P. R. (1990) · PubMed · Cited by 111 · see citing works

Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA

Lin, P. J. C., Tam, Y. Y. C., Hafez, I. M., Sandhu, A. P., Chen, S., Ciufolini, M. A., Nabi, I. R., & Cullis, P. R. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.019 · Cited by 101 · see citing works

Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles

Crawford, R., Dogdas, B., Keough, E., Haas, R. M., Wepukhulu, W., Krotzer, S., Burke, P. A., Sepp‐Lorenzino, L., Bagchi, A., & Howell, B. J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.025 · Cited by 96 · see citing works

Lipoprotein structure

Jonas, A., & Phillips, M. C. (2008) · Elsevier eBooks · doi:10.1016/b978-044453219-0.50019-2 · Cited by 90 · see citing works

Immune Stimulation by a CpG-Containing Oligodeoxynucleotide Is Enhanced When Encapsulated and Delivered in Lipid Particles

Mui, B. L., Raney, S. G., Semple, S. C., & Hope, M. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29491-x · Cited by 89 · see citing works

Influenza vaccines: The virosome concept

Wilschut, J. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.11.006 · Cited by 86 · see citing works

Quantitative evaluation of siRNA delivery in vivo

Pei, Y., Hancock, P. J., Zhang, H., Bartz, R., Cherrin, C., Innocent, N., Pomerantz, C. J., Seitzer, J. L., Koser, M. L., Abrams, M. T., et al. (2010) · RNA · doi:10.1261/rna.2255810 · Cited by 82 · see citing works

Optimization of the retention properties of vincristine in liposomal systems

Boman, N. L., Mayer, L. D., & Cullis, P. R. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90256-y · Cited by 80 · see citing works

Use of nanoscale delivery systems to maintain synergistic drug ratiosin vivo

Dicko, A., Mayer, L. D., & Tardi, P. G. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.538678 · Cited by 75 · see citing works

Velocity profiles and shear strain rate variability in the USP Dissolution Testing Apparatus 2 at different impeller agitation speeds

Bai, G., Wang, Y., & Armenante, P. M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.09.022 · Cited by 72 · see citing works

Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line

Leonetti, C., Biroccio, A., Benassi, B., Stringaro, A., Stoppacciaro, A., Semple, S. C., & Zupi, G. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700326 · Cited by 66 · see citing works

Molecular Mechanism of Apolipoprotein E Binding to Lipoprotein Particles

Nguyen, D., Dhanasekaran, P., Phillips, M. C., & Lund‐Katz, S. (2009) · Biochemistry · doi:10.1021/bi9000694 · Cited by 63 · see citing works

Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA

Ursic-Bedoya, R. J., Mire, C. E., Robbins, M., Geisbert, J. B., Judge, A. D., MacLachlan, I., & Geisbert, T. W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit465 · Cited by 59 · see citing works

Membrane perturbation and the mechanism of lipid-mediated transfer of DNA into cells

Mui, B. L., AHKONG, Q. F., Chow, L., & Hope, M. J. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00226-1 · Cited by 53 · see citing works

Enhanced Anti-Inflammatory Activity of a Liposomal Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide in an Acute Model of Contact Hypersensitivity

Klimuk, S. K., Semple, S. C., Nahirney, P. C., Mullen, M. C., Bennett, C. F., Scherrer, P., & Hope, M. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35316-9 · Cited by 46 · see citing works

Structural Requirements for Cationic Lipid Mediated Phosphorothioate Oligonucleotides Delivery to Cells in Culture

Bennett, C. F., Mirejovsky, D., Crooke, R. M., Tsai, Y.-L., Felgner, J. H., Sridhar, C. N., Wheeler, C. J., & Felgner, P. L. (1998) · Journal of drug targeting · doi:10.3109/10611869808995870 · Cited by 42 · see citing works

Misinterpreting the therapeutic effects of siRNA caused by immune stimulation

Robbins, M., Judge, A. D., Ambegia, E., Choi, C., Yaworski, E., Palmer, L., McClintock, K., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hgt.2008.131 · Cited by 41 · see citing works

Phase II Study of Vincristine Sulfate Liposome Injection (Marqibo) and Rituximab for Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma in Need of Palliative Therapy

Kaplan, L. D., Deitcher, S. R., Silverman, J. A., & Morgan, G. J. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.09.009 · Cited by 36 · see citing works

Long term results of a phase 2 study of vincristine sulfate liposome injection ( M arqibo ® ) substituted for non‐liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non‐ H odgkin lymphomas

Hagemeister, F. B., Rodriguez, M. A., Deitcher, S. R., Younes, A., Fayad, L., Goy, A. H., Dang, N. H., Forman, A. D., McLaughlin, P. J., Medeiros, L. J., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12446 · Cited by 35 · see citing works

Antitumor Efficacy of bcl-2 and c-myc Antisense Oligonucleotides in Combination with Cisplatin in Human Melanoma Xenografts: Relevance of the Administration Sequence

Zupi, G., Scarsella, M., Semple, S. C., Mottolese, M., Natali, P. G., & Leonetti, C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1284 · Cited by 28 · see citing works

Therapeutic integration of c‐myc and bcl‐2 antisense molecules with docetaxel in a preclinical model of hormone‐refractory prostate cancer

Leonetti, C., Biroccio, A., D’Angelo, C., Semple, S. C., Scarsella, M., & Zupi, G. (2007) · The Prostate · doi:10.1002/pros.20636 · Cited by 23 · see citing works

Intravenous Administration of Stabilized Antisense Lipid Particles (SALP) Leads to Activation and Expansion of Liver Natural Killer Cells

Bramson, J. L., Bodner, C. A., JOHNSON, J., SEMPLE, S., & Hope, M. J. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.217 · Cited by 6 · see citing works

Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals

Thess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., & Schlake, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.103 · Cited by 513 · see citing works

Lipid-based nanoparticle formulations for small molecules and RNA drugs

Ickenstein, L. M., & Garidel, P. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1669558 · Cited by 193 · see citing works

Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles

Bost, J., Barriga, H. M. G., Holme, M. N., Gallud, A., Maugeri, M., Gupta, D., Lehto, T., Valadi, H., Esbjörner, E. K., Stevens, M. M., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c05099 · Cited by 187 · see citing works

Lipid nanoparticles for targeted siRNA delivery - going from bench to bedside

Zatsepin (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s106625 · Cited by 162 · see citing works

Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanisms

de Jesus, M. B., & Zuhorn, I. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.010 · Cited by 141 · see citing works

Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity

Liu, G., Zhu, M., Zhao, X., & Nie, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113889 · Cited by 114 · see citing works

Structural analysis of nanoparticulate carriers for encapsulation of macromolecular drugs

Angelov, B., Garamus, V. M., Drechsler, M., & Angelova, A. (2016) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2016.11.064 · Cited by 68 · see citing works

Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting

Shobaki, N., Sato, Y., & Harashima, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s188016 · Cited by 65 · see citing works

Efficient Delivery of DNA Using Lipid Nanoparticles

Cui, L., Renzi, S., Quagliarini, E., Digiacomo, L., Amenitsch, H. W., Masuelli, L., Bei, R., Ferri, G., Cardarelli, F., Wang, J., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081698 · Cited by 52 · see citing works

Method of carrier-free delivery of therapeutic RNA importable into human mitochondria: Lipophilic conjugates with cleavable bonds

Dovydenko, I. S., Tarassov, I., Venyaminova, A. G., & Entelis, N. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.075 · Cited by 39 · see citing works

Linear Polyethylenimine-DNA Nanoconstruct for Corneal Gene Delivery

Rodier, J. T., Tripathi, R., Fink, M. K., Sharma, A., Korampally, M., Gangopadhyay, S., Giuliano, E. A., Sinha, P. R., & Mohan, R. R. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0024 · Cited by 29 · see citing works

Structural and componential design: new strategies regulating the behavior of lipid-based nanoparticles in vivo

Zhong, Q., Zheng, C., Yi, K., Mintz, R. L., Lv, S., Tao, Y., & Li, M. (2023) · Biomaterials Science · doi:10.1039/d3bm00387f · Cited by 26 · see citing works

Messenger RNA as a Novel Therapeutic Approach

Stanton, M. G., & Murphy-Benenato, K. E. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2016_30 · Cited by 16 · see citing works

Nanoparticles as nucleic acid delivery vectors

Sharma, A. K., Gupta, L., & Gupta, U. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100557-6.00002-x · Cited by 16 · see citing works

Anti-c-myc cholesterol based lipoplexes as onco-nanotherapeutic agents in vitro

Habib, S., Daniels, A. N., Ariatti, M., & Singh, M. (2021) · F1000Research · doi:10.12688/f1000research.25142.2 · Cited by 12 · see citing works

Anti-c-myc cholesterol based lipoplexes as onco-nanotherapeutic agents in vitro

Habib, S., Daniels, A. N., Ariatti, M., & Singh, M. (2020) · F1000Research · doi:10.12688/f1000research.25142.1 · Cited by 11 · see citing works

A simplified method for manufacturing RNAi therapeutics for local administration

Ando, H., Lila, A. S. A., Fukushima, M., Matsuoka, R., Shimizu, T., Okuhira, K., Ishima, Y., Huang, C., Wada, H., & Ishida, T. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.054 · Cited by 5 · see citing works

Lipoplexes Strengthened by Anionic Polymers: Easy Preparation of Highly Effective siRNA Vectors Based on Cationic Lipids and Anionic Polymers

Arruda, D. C., Schlegel, A., Bigey, P., & Escriou, V. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3718-9_8 · Cited by 5 · see citing works

Moving Liposome Technology from the Bench to the Oncological Patient: Towards Performance-by-Design

Cruz, A. F., Fonseca, N. A., Gregório, A. C., Moura, V., Simões, S., & Moreira, J. N. (2018) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-94174-5_4 · Cited by 2 · see citing works

RNome in Cancer Therapy

Arora, M., & Kaul, D. (2018) · Springer eBooks · doi:10.1007/978-981-13-1568-8_4 · Cited by 1 · see citing works

Effects of Core and Shell Modification to Tethered Nanoassemblies on siRNA Therapy

Rheiner, S. (2017) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2017.272

Features of electron-microscopic visualization of soft phospholipid nanoparicles

Poletaeva, Y. E., Grigor, A. E., Dovydenko, I. S., & Ryabchikova, E. I. (2018) · Proceedings of the Voronezh State University of Engineering Technologies · doi:10.20914/2310-1202-2017-4-191-196

Lipid nanoparticle delivery systems for siRNA-based therapeutics

Wan, C. P. L., Allen, T. M., & Cullis, P. R. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0161-z · Cited by 194 · see citing works

Ionizable Lipid Nanoparticles as a siRNA Delivery Carrier: A Review

Prajapat, V., Sharma, G., Dhania, N. K., & Maparu, A. K. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.6c03278

Lipid nanoparticles for hepatic delivery of small interfering RNA

Yu, B., Hsu, S., Zhou, C., Wang, X., Terp, M. C., Wu, Y., Teng, L., Mao, Y., Wang, F., Xue, W., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.002 · Cited by 72 · see citing works

Lipid nanoparticle technology in liver-directed gene therapy

Zhong, W. (2024) · CRC Press eBooks · doi:10.1201/9781003587590-25

Advances in lipid nanoparticles for siRNA delivery

Tam, Y., Chen, S., & Cullis, P. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5030498 · Cited by 229 · see citing works